ACTO Named Among Everest Group's Top 50™ Pharmaceutical Technology Providers for 2026
<p>Recognition underscores ACTO's leadership in AI-powered field excellence and agentic AI purpose-built for Life Sciences TORONTO and NEW YORK, Sept. 14, 2026 /PRNewswire/ -- ACTO, uniting human intelligence with empathetic AI in Life Sciences, today announced its inclusion in Everest...</p>
Read original article ↗
Related Articles
Knak Expands Its AI Production Layer to Mobile as RCS Business Use Grows
Enterprise demand for marketing production increases as brands look to add more channels and strengthen marketing perfor
Industry-First, AI-Native Capabilities Make It Easy to Optimize the Use of Multiple Carriers While Lowering Costs and Im
SHANGHAI, Sept. 14, 2026 /PRNewswire/ -- MoleculeMind, an AI-native bioengineering infrastructure company, announced tha
LaFontaine's 40+ locations across Michigan will bring UVeye's "MRI for Cars" technology closer to drivers statewide, exp